Market Cap

Beijing Hotgen Biotech Co. Ltd Market Capitalization:

CN¥16.25 Billion

CNY as of Jan. 1, 2026

US$2.32 Billion

business Beijing Hotgen Biotech Co. Ltd Company Profile

Beijing Hotgen Biotech Co. Ltd Main Stock Listing

SSE: 688068

Market Capitalization History of Beijing Hotgen Biotech Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Beijing Hotgen Biotech Co. Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2026 CN¥16.25 B 162.30%
Jan. 1, 2025 CN¥6.20 B 64.46%
Jan. 1, 2024 CN¥3.77 B -30.81%
Jan. 1, 2023 CN¥5.44 B -56.97%
Jan. 1, 2022 CN¥12.65 B 260.68%
Jan. 1, 2021 CN¥3.51 B -46.11%
Jan. 1, 2020 CN¥6.51 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Beijing Hotgen Biotech Co. Ltd Categories

China languages Healthcare languages Biotechnology
China Healthcare China Biotechnology

Stocks & Indices

Beijing Hotgen Biotech Co. Ltd has the following listings and related stock indices.


Stock: SSE: 688068

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.